News + Insights

Strong Claims Build Foundation for Patents Scientists don’t need to be lawyers, but they do need to understand how claims define, narrow, and protect therapeutic innovations.
Danielle Gerhard, PhD
SPARK NS and Haukeland Univ Hospital Begin Parkinson's Clinical Trial
Susan Thomas
Closing the Gap Between Academic Research and Patient Impact
Ariella Bersan Video
Behind Every Parkinson’s Researcher, There’s a Story
Ariella Bersan
What Surprised an Academic About Drug Development
Daria Mochly-Rosen, PhD
Starting with the End in Mind
Opher Kornfeld, PhD
Identifying Unmet Medical Need
Kevin Grimes, MD, MBA

Spotlight

Michael Rapé, PhD: Targeting Mitochondria to Treat Parkinson’s Disease

A surprising discovery about cellular stress responses led Michael Rapé and his team to develop a small molecule that may help restore mitochondrial function in Parkinson’s disease.

Spotlight

Michael Rapé, PhD, University of California, Berkeley, and HHMI

Get Involved

Call for Proposals

SPARK NS is no longer accepting applications for the SPARK NS Translational Research Program, 2027 Cohort. For information about future application cycles, stay in touch with SPARK NS.

Explore the SPARK NS Translational Research Program

The funding and high-level of support provided by our program helps ensure that each project selected for participation meets its translational objectives and continues on the path to market.

LearnMore